RPL17 and cervical cancer: Studies conducted recently reveal that the T-cells from cervical cancer patients display a heightened expression of PD-1, which leads to a greater production of TGF-β and IL-10, decreased levels of IFN-γ, and impaired T-cell proliferation, thereby establishing immunological tolerance and facilitating tumor growth [135,137].